The u.s. pharmaceutical company Gilead Sciences will take 390 dollars per dose for the company's drug Remdesivir for the treatment of corona virus.
Price is for the governments of the UNITED states and other developed countries. It informs the company in an announcement on Monday, writes Ritzau Finance.
According to Gilead is expected the majority of patients to receive the treatment for five days. And it takes six doses of Remdesivir, which has been shown to have a good ability to rein in coronavirusset.
Thus, the overall treatment in most cases run up into the 2340 dollar. It is the equivalent of about 15.500 euros.
Medicinalselskabet have chosen to set the same price for the developed countries the world over to avoid having to negotiate the price with each country.
- Price will be offered to all governments in developed countries around the world, where Remdesivir is approved for the treatment, informs Gilead in the message.
In developing countries, the company has also entered into agreements with manufacturers to provide treatment for a significantly lower price.
Remdesivir is a preparation that inhibits the virus. It is taken in use for the treatment of seriously ill coronapatienter in Denmark.
It has also been approved for the treatment of The European medicines Agency (EMA).
It is a tool that was originally developed to treat hepatitis and as possible remedy against ebola.
the Company will initially sell the product to the authorities the world over. When there is more time in the supply of the drug, will Gilead also begin to sell it through the normal distribution channels.
Gilead has in the past promised that the company would donate the drug for the whole of June, and the promise is still in power, writes Ritzau Finance.
In studies, the drug has shown that it can reduce mortality and indlæggelsestiden for patients with Covid-19. But it must be given at specific times in the course of the disease.